Hans-joerg Meisel

Halle, NI, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Artificial Intelligence Chatbot Responses to Patient Queries on Traumatic Brain Injury: An Expert Assessment of Reliability and Accuracy.

Artificial Intelligence Chatbot Responses to Patient Queries on Traumatic Brain Injury: An Expert Assessment of Reliability and Accuracy.

Journal: Journal of neurotrauma

Published: December 03, 2025

Bracing and Activity Restriction After Lumbar Discectomy Surgery: An International Survey of AO Spine Members.

Bracing and Activity Restriction After Lumbar Discectomy Surgery: An International Survey of AO Spine Members.

Journal: Neurospine

Published: November 17, 2025

Real-world two-year durability of restorative neurostimulation for treatment of multifidus dysfunction in patients with chronic low back pain: an observational German cohort study.

Real-world two-year durability of restorative neurostimulation for treatment of multifidus dysfunction in patients with chronic low back pain: an observational German cohort study.

Journal: European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society

Published: September 26, 2025

Practice preference of revision surgery for recurrent lumbar disc herniation: an international survey of AO spine members.

Practice preference of revision surgery for recurrent lumbar disc herniation: an international survey of AO spine members.

Journal: European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society

Published: July 17, 2025

Decompression-Only for Lumbar Degenerative Spondylolisthesis - What are the Risk for Failure? - A Systematic Review.

Decompression-Only for Lumbar Degenerative Spondylolisthesis - What are the Risk for Failure? - A Systematic Review.

Journal: Global spine journal

Published: May 15, 2025

M2a macrophages identified as a potential therapeutic candidate for intervertebral disc herniation regression.

M2a macrophages identified as a potential therapeutic candidate for intervertebral disc herniation regression.

Journal: Osteoarthritis and cartilage open

Published: April 09, 2025

Framework for Adoption of Enabling Technologies for Improved Outcomes in Spine Surgery.

Framework for Adoption of Enabling Technologies for Improved Outcomes in Spine Surgery.

Journal: Global spine journal

Published: February 20, 2025

How Reliable is the Assessment of Fusion Status Following ACDF Using Dynamic Flexion-Extension Radiographs?

How Reliable is the Assessment of Fusion Status Following ACDF Using Dynamic Flexion-Extension Radiographs?

Journal: Global spine journal

Published: December 06, 2024

Rate of Reoperation Following Decompression-Only Procedure for Lumbar Degenerative Spondylolisthesis: A Systematic Review of Literature.

Rate of Reoperation Following Decompression-Only Procedure for Lumbar Degenerative Spondylolisthesis: A Systematic Review of Literature.

Journal: JB & JS open access

Published: July 08, 2024

Discectomy versus sequestrectomy in the treatment of lumbar disc herniation: a systematic review and meta-analysis.

Discectomy versus sequestrectomy in the treatment of lumbar disc herniation: a systematic review and meta-analysis.

Journal: The spine journal : official journal of the North American Spine Society

Published: May 23, 2024

Radiographic Risk Factors for Adjacent Segment Disease Following Anterior Cervical Discectomy and Fusion (ACDF): A Systematic Review and Meta-Analysis.

Radiographic Risk Factors for Adjacent Segment Disease Following Anterior Cervical Discectomy and Fusion (ACDF): A Systematic Review and Meta-Analysis.

Journal: Global spine journal

Published: March 12, 2024

Allogenic bone marrow-derived mesenchymal stromal cell-based therapy for patients with chronic low back pain: a prospective, multicentre, randomised placebo controlled trial (RESPINE study).

Allogenic bone marrow-derived mesenchymal stromal cell-based therapy for patients with chronic low back pain: a prospective, multicentre, randomised placebo controlled trial (RESPINE study).

Journal: Annals of the rheumatic diseases

Published: March 06, 2024

Showing 1-12 of 48

Last Updated: 09/26/2026